A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease
|Start Date:||May 2017|
|Primary Completion Date:
|Study Completion Date:
||Heart, Blood & Circulatory - Other|
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Stay informed about new Trial Results Summaries with our email notification service
|United States of America, CA|| Glendale, CA, United States of America, 91206|